Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Business

Pronova BioPharma ASA : Mandatory notification of trade


Print article Print article
Copyright © Thomson Reuters 2012. All rights reserved.
2012-11-21 07:09:34 -

Mandatory notification of trade

Reference is made to the announcement from Pronova BioPharma ASA ("Pronova")
today regarding the voluntary offer from BASF to acquire all the shares of
Pronova for NOK 12.50 per share (the "Offer").

Trygve Christian Moe (board member of Pronova) has on 20 November 2012 pre-
accepted the Offer for the 7,000 shares held by him in Pronova. Following a
successful completion of the Offer he will not hold any shares in Pronova.

J&J Future Invest AS, a close associate of Hilde Furberg (board member of
Pronova), has on 20 November 2012 pre-accepted the Offer for the 60,000 shares
held by it in Pronova. Following a successful completion of the Offer Hilde
Furberg and J&J Future Invest AS will not hold any shares in Pronova.

Sverre Magne Sondbø 
(board member of Pronova) has on 20 November 2012 pre- accepted the Offer for the 11,000 shares held by him in Pronova. Following a successful completion of the Offer he will not hold any shares in Pronova. Roger Næss (deputy board member) has on 20 November 2012 pre-accepted the Offer for the 500 shares held by him in Pronova. Following a successful completion of the Offer he will not hold any shares in Pronova. Jurs AS a close associate of Morten Jurs (Chief Executive Officer of Pronova) has on 20 November 2012 pre-accepted the Offer for the 529,375 shares held by it in Pronova. Following a successful completion of the Offer Morten Jurs and Jurs AS will not hold any shares in Pronova. Synne H. Røine (Chief Financial Officer of Pronova) has on 20 November 2012 pre- accepted the Offer for the 3,500 shares held by her in Pronova. Following a successful completion of the Offer she will not hold any shares in Pronova. Maxfield AS, a close associate of Hilde Steineger (Vice President Business Development of Pronova), has on 20 November 2012 pre-accepted the Offer for the 10,500 shares held by it in Pronova. Following a successful completion of the Offer Hilde Steineger and Maxfield AS will not hold any shares in Pronova. Charlotte Berg-Svendesen (Vice President Legal Affairs of Pronova) has on 20 November 2012 pre-accepted the Offer for the 1,000 shares held by her in Pronova. Following a successful completion of the Offer she will not hold any shares in Pronova. Knut Sandvold (Vice President Human Resources of Pronova) has on 20 November 2012 pre-accepted the Offer for the 31,500 shares held by him in Pronova. Following a successful completion of the Offer he will not hold any shares in Pronova. Espelund AS a close associate of Trygve Christophersen (Vice President Supply Chain of Pronova) has on 20 November 2012 pre-accepted the Offer for the 179,125 shares held by it in Pronova. Following a successful completion of the Offer Trygve Christophersen and Espelund AS will not hold any shares in Pronova. Nala Invest AS, a close associate of Hilde Merete Næss (Vice President Quality Affairs of Pronova), has on 20 November 2012 pre-accepted the Offer for the 99,989 shares held by it in Pronova. Following a successful completion of the Offer Hilde Merete Næss and Nala Invest AS will not hold any shares in Pronova. This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act. This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that: (i) the releases contained herein are protected by copyright and other applicable laws; and (ii) they are solely responsible for the content, accuracy and originality of the information contained therein. Source: Pronova BioPharma ASA via Thomson Reuters ONE [HUG#1659667]


Press Information:




Contact Person:


Disclaimer: © 2013 Thomson Reuters. The press releases or report contained herein is protected by copyright and other applicable laws, treaties and conventions. Information contained in the releases is furnished by Thomson Reuters's, who warrant that they are solely responsible for the content, accuracy and originality of the information contained therein. All reproduction, other than for an individual user's personal reference, is prohibited without prior written permission.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com | BidVertiser